Tesla is about to show a snapshot of its global sales. Is recent optimism deserved?
Wall Street sales consensus has crept up, but some worry that a sales bump, if it comes, will be more about a rush to buy EVs ahead of expiring U.S. tax incentives.
—-
Warner Bros. Notches Another Box Office Win. ‘One Battle After Another’ Tops Sales.
The crime thriller puts Warner Bros. on pace to match or beat its 2011 record of top movie debuts, according to Comscore.
—-
Walmart CEO Issues Wake-Up Call: ‘AI Is Going to Change Literally Every Job’
The country’s largest private employer says its head count will stay flat over the next three years, despite plans to grow, as AI eliminates some roles and transforms others.
—-
Drug Tariffs Are a Sideshow. Trump’s Next Move Could Hit Pharma Harder.
What unnerves investors is a lack of clarity on drug pricing.
—-
Trump Calls for Firing of Microsoft Global Affairs Chief
Lisa Monaco served as deputy attorney general and homeland security adviser under the Biden administration.
—-
The CEO Charged With Bringing Nissan Back From the Brink
Like Carlos Ghosn before him, Ivan Espinosa is trying to return the carmaker to profitability-and ensure it survives.
—-
Sinclair, Nexstar Will Bring Kimmel Back to Their ABC Affiliates
The broadcasters said they have had discussions with Disney and remain committed to free speech.
—-
Gramercy Collects $760 Million for Private-Credit Deals
The emerging-markets specialist is aiming to raise $1.5 billion for the pool and targets investments in Latin America.
—-
Videogame Giant Electronic Arts Nears Roughly $50 Billion Deal to Go Private
Investors including Silver Lake are eyeing a deal that would likely be the largest leveraged buyout ever.
—-
Big Pharma Unfazed by Trump Tariffs, but Small Biotechs Face Vulnerability
Drugmakers have been bracing for levies and sought to get ahead of them with pledges to invest billions more on domestic manufacturing.
—-
Six Flags Is Under Activist Pressure to Sell Its Real Estate
Land & Buildings Investment Management has about a 2% stake in the theme-park operator.
—-
AstraZeneca to Offer Discounted Drugs as Trump Pressures Pharma Industry to Cut Prices
AstraZeneca said it will offer its asthma and diabetes drugs at an up to 70% discount in the U.S. ahead of a Trump administration deadline for pharmaceutical companies to cut drug prices.
—-
Boeing Clears Key Hurdle From 737 MAX Crashes
The aerospace giant is regaining some authority from regulators to perform final safety checks on jets.
—-
Amgen to Invest $650 Million in U.S. Production Expansion as Trump Hikes Tariffs
The investment was announced a day after President Trump said he would impose a 100% tariff on pharmaceuticals produced by companies that are not building plants in the U.S.
—-
Banks Ordered to Dig Through Account Closures to Find ‘Debanking’ Cases
Regulators demand information going back years as part of President Trump’s crackdown on alleged political or religious discrimination.
(END) Dow Jones Newswires
September 28, 2025 21:15 ET (01:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.